Comparison Overview
Gilead HIV

Gilead HIV
333 Lakeside Dr, Foster City, 94404, US
Last Update: 08/03/2026
Decades of breakthrough science, bold partnerships, and tireless advocacy turned HIV from a fatal diagnosis to one that could be managed and prevented. We’re driving the next era of HIV innovation to support the wellness of all people impacted by it. Social Media Gui...

Roche
Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH
Last Update: 20/05/2026
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...
Compliance Ranges Comparison

Gilead HIV







Roche






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Gilead HIV in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Roche in 2026.
Incident History - Gilead HIV (X = Date, Y = Severity)
Gilead HIV cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Roche (X = Date, Y = Severity)
Roche cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Gilead HIV

Roche
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.